Figure 2.
Subcutaneous low-dose IL-2 increases the number of circulating endogenous Tregs. (A) Treg/Tconv ratio × 100 in animals treated with IL-2+rapa and rapa alone. *P < .05, repeated-measures ANOVA. (B) Percentages (left panel) of circulating Tregs defined as a total percentage of CFSE+ cells (of CD3+CD4+) plus endogenous cells as gated in panel A (green) and endogenous cells as gated in panel A alone (purple). Absolute numbers (right panel) of circulating Tregs defined as an absolute number of CFSE+ cells (CD3+CD4+) per microliter peripheral blood plus absolute endogenous cells as calculated in panel A (green) and endogenous cells as calculated in panel B alone (purple).

Subcutaneous low-dose IL-2 increases the number of circulating endogenous Tregs. (A) Treg/Tconv ratio × 100 in animals treated with IL-2+rapa and rapa alone. *P < .05, repeated-measures ANOVA. (B) Percentages (left panel) of circulating Tregs defined as a total percentage of CFSE+ cells (of CD3+CD4+) plus endogenous cells as gated in panel A (green) and endogenous cells as gated in panel A alone (purple). Absolute numbers (right panel) of circulating Tregs defined as an absolute number of CFSE+ cells (CD3+CD4+) per microliter peripheral blood plus absolute endogenous cells as calculated in panel A (green) and endogenous cells as calculated in panel B alone (purple).

or Create an Account

Close Modal
Close Modal